Highlights

  • Novavax's vaccine gets approved for children
  • Novavax: vaccine was 80% effective against Covid-19
  • In India, Covovax is manufactured by Serum Institute of India.

Latest news

Investor Nicole Junkermann says India has Structural Advantage in Global Artificial Intelligence Race

Investor Nicole Junkermann says India has Structural Advantage in Global Artificial Intelligence Race

Punjab T10 Cricket League Rescheduled; Action to Now Take Place from June 14 to 20 in Amritsar

Punjab T10 Cricket League Rescheduled; Action to Now Take Place from June 14 to 20 in Amritsar

Quad to launch critical minerals framework to strengthen critical mineral supply chains in Indo-Pacific: US Secretary of State

Quad to launch critical minerals framework to strengthen critical mineral supply chains in Indo-Pacific: US Secretary of State

India Semiconductor Mission launches 'Investors Support' portal to assist Semiconductor Investors

India Semiconductor Mission launches 'Investors Support' portal to assist Semiconductor Investors

M416 Glacier Rewards Return in BGMI's Latest Redeem Code Reveal

M416 Glacier Rewards Return in BGMI's Latest Redeem Code Reveal

BTS returns to AMAs stage after four years with pre-taped 'Hooligan' performance

BTS returns to AMAs stage after four years with pre-taped 'Hooligan' performance

Decathlon's 'Sports Utsav 2026' Celebrates Movement, Engaging 200K+ Participants Across 125 Stores Pan-India

Decathlon's 'Sports Utsav 2026' Celebrates Movement, Engaging 200K+ Participants Across 125 Stores Pan-India

India, Canada push for early trade deal; PM Mark Carney calls CEPA 'Game Changer'

India, Canada push for early trade deal; PM Mark Carney calls CEPA 'Game Changer'

Covovax gets emergency use approval for children aged 12-17 in India

Covovax is the fourth Covid-19 vaccine to be authorised for adolescents aged 12 years and older in India after Biological E's Corbevax, Zydus Cadila's ZyCoV-D and Bharat Biotech's Covaxin.

Covovax gets emergency use approval for children aged 12-17 in India

American biotechnology company Novavax has said that its Covid-19 vaccine has got emergency use authorisation for children in 12-17 years age group by India's drug regulator.

The company has claimed that its vaccine produced an immune response in the same age group in a mid- to late-stage study involving 460 Indian adolescents.

Last month Novavax had said its vaccine was 80% effective against Covid-19 in a late-stage trial testing the shot in 2,247 children aged 12 to 17 years.

The vaccine is manufactured in India by Serum Institute of India under the name of Covovax

Also watch: Covovax Explained: Adding another weapon to India's Covid arsenal

Covovax is the fourth Covid-19 vaccine to be authorised for adolescents aged 12 years and older in India after Biological E's Corbevax, Zydus Cadila's ZyCoV-D and Bharat Biotech's Covaxin.

ADVERTISEMENT

Up Next

Covovax gets emergency use approval for children aged 12-17 in India

Covovax gets emergency use approval for children aged 12-17 in India

Union minister says India's Covid vaccine programme more advanced than USA's

Union minister says India's Covid vaccine programme more advanced than USA's

Covid-19: minor drop in cases, deaths across India in 24 hours

Covid-19: minor drop in cases, deaths across India in 24 hours

Covid: India's daily new infections, active cases decline

Covid: India's daily new infections, active cases decline

Covid: India's active cases decline after nearly 70 days

Covid: India's active cases decline after nearly 70 days

Covid 19: India records 12,193 cases in last 24 hours

Covid 19: India records 12,193 cases in last 24 hours

ADVERTISEMENT

editorji-whatsApp

More videos

Covid surge: Centre asks states to keep strict vigil, take pre-emptive action

Covid surge: Centre asks states to keep strict vigil, take pre-emptive action

Tripura makes covid test mandatory for people arriving from states with high positivity rate

Tripura makes covid test mandatory for people arriving from states with high positivity rate

Covid: India sees slower rise in daily cases; 27 deaths in one day

Covid: India sees slower rise in daily cases; 27 deaths in one day

Delhi adds 1,396 Covid cases, positivity rate mounts to 31.9 per cent

Delhi adds 1,396 Covid cases, positivity rate mounts to 31.9 per cent

Covid entering endemic stage in India, cases likely to subside after 10-12 days

Covid entering endemic stage in India, cases likely to subside after 10-12 days

Covid: USA ends 'national emergency' after over 3 years

Covid: USA ends 'national emergency' after over 3 years

Nationwide Covid-19 drills begin to assess preparedness as cases surge

Nationwide Covid-19 drills begin to assess preparedness as cases surge

'The reason could be...': Indian Medical Association on surge in Covid-19 cases

'The reason could be...': Indian Medical Association on surge in Covid-19 cases

Covid cases likely to rise in the coming days, says Delhi health minister Saurabh Bhardwaj

Covid cases likely to rise in the coming days, says Delhi health minister Saurabh Bhardwaj

Battling long-Covid, this US woman smelled coffee after over 2 years | Watch her 1st reaction

Battling long-Covid, this US woman smelled coffee after over 2 years | Watch her 1st reaction

Editorji Technologies Pvt. Ltd. © 2022 All Rights Reserved.